Yan Z, Gu Q, Yin H, Yi M, Wang X, Sun R
Eat Weight Disord. 2024; 29(1):76.
PMID: 39612146
PMC: 11607027.
DOI: 10.1007/s40519-024-01706-z.
Wu W, Hou C, Wu W, Shen H, Zeng Y, Chen L
Front Pediatr. 2024; 12:1467020.
PMID: 39564383
PMC: 11573574.
DOI: 10.3389/fped.2024.1467020.
Nenna R, Petrella C, Bonci E, Papoff P, Jorgi M, Petrarca L
Curr Neuropharmacol. 2024; 22(14):2433-2442.
PMID: 39403060
PMC: 11451311.
DOI: 10.2174/1570159X22999240223153901.
Liang J, Ma T, Li Y, Sun R, Zhao S, Shen Y
Heliyon. 2024; 10(10):e30699.
PMID: 38770343
PMC: 11103434.
DOI: 10.1016/j.heliyon.2024.e30699.
Zhu N, Zhu J, Lin S, Yu H, Cao C
BMC Public Health. 2024; 24(1):353.
PMID: 38308244
PMC: 10835908.
DOI: 10.1186/s12889-024-17811-8.
Considerations for Use of Blood-Based Biomarkers in Epidemiologic Dementia Research.
Hayes-Larson E, Ackley S, Turney I, La Joie R, Mayeda E, Glymour M
Am J Epidemiol. 2023; 193(3):527-535.
PMID: 37846130
PMC: 10911539.
DOI: 10.1093/aje/kwad197.
Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19.
Zingaropoli M, Pasculli P, Barbato C, Petrella C, Fiore M, Dominelli F
Cells. 2023; 12(18).
PMID: 37759493
PMC: 10526816.
DOI: 10.3390/cells12182270.
Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment.
Ghezzi A, Neuteboom R
Neurol Ther. 2023; 12(6):1867-1881.
PMID: 37682513
PMC: 10630260.
DOI: 10.1007/s40120-023-00535-z.
Review of Neurofilaments as Biomarkers in Sepsis-Associated Encephalopathy.
Zhang Q, Fan W, Sun J, Zhang J, Yin Y
J Inflamm Res. 2023; 16:161-168.
PMID: 36660377
PMC: 9843472.
DOI: 10.2147/JIR.S391325.
Neurofilaments contribution in clinic: state of the art.
Delaby C, Bousiges O, Bouvier D, Fillee C, Fourier A, Mondesert E
Front Aging Neurosci. 2022; 14:1034684.
PMID: 36389064
PMC: 9664201.
DOI: 10.3389/fnagi.2022.1034684.
Neurodegeneration and convergent factors contributing to the deterioration of the cytoskeleton in Alzheimer's disease, cerebral ischemia and multiple sclerosis (Review).
Gutierrez-Vargas J, Castro-Alvarez J, Zapata-Berruecos J, Abdul-Rahim K, Arteaga-Noriega A
Biomed Rep. 2022; 16(4):27.
PMID: 35251614
PMC: 8889542.
DOI: 10.3892/br.2022.1510.
Serum Neurofilament Light: a Potential Diagnostic and Prognostic Biomarker in Obstetric Posterior Reversible Encephalopathy Syndrome.
Fang X, Liang Y, Zhang W, Wang Q, Chen J, Chen J
Mol Neurobiol. 2021; 58(12):6460-6470.
PMID: 34550542
DOI: 10.1007/s12035-021-02562-z.
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19.
Aamodt A, Hogestol E, Popperud T, Holter J, Dyrhol-Riise A, Tonby K
J Neurol. 2021; 268(10):3574-3583.
PMID: 33743046
PMC: 7980743.
DOI: 10.1007/s00415-021-10517-6.
Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS.
Schneider R, Bellenberg B, Gisevius B, Hirschberg S, Sankowski R, Prinz M
Neurol Neuroimmunol Neuroinflamm. 2020; 8(1).
PMID: 33172960
PMC: 7713721.
DOI: 10.1212/NXI.0000000000000906.
Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease.
Shribman S, Heller C, Burrows M, Heslegrave A, Swift I, Foiani M
Mov Disord. 2020; 36(2):503-508.
PMID: 33078859
PMC: 8436757.
DOI: 10.1002/mds.28333.
Molecular biomarkers in multiple sclerosis.
Ziemssen T, Akgun K, Bruck W
J Neuroinflammation. 2019; 16(1):272.
PMID: 31870389
PMC: 6929340.
DOI: 10.1186/s12974-019-1674-2.
Vitamin D Supplementation as Add-on Therapy in Multiple Sclerosis-Balance between Benefit and Risk?: A Commentary on Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is Enough.
Goischke H
Int J Mol Sci. 2019; 20(6).
PMID: 30917564
PMC: 6471226.
DOI: 10.3390/ijms20061513.
